Comment le bénéfice par action récent de QDEL se compare-t-il aux attentes ?
Comment les revenus de QuidelOrtho Corp QDEL se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour QuidelOrtho Corp ?
Quel est le score de qualité des bénéfices pour QuidelOrtho Corp ?
Quand QuidelOrtho Corp publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de QuidelOrtho Corp ?
QuidelOrtho Corp a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$29.1
Prix d'ouverture
$29.21
Plage de la journée
$27.75 - $29.53
Plage de 52 semaines
$19.5 - $43.92
Volume
679.7K
Volume moyen
1.0M
BPA (TTM)
-17.36
Rendement en dividend
--
Capitalisation boursière
$1.9B
Qu’est-ce que QDEL ?
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.